Toward understanding the molecular pathology of huntington's disease

Brain Pathology

Volumn 7, Issue 3, 1997, Pages 979-1002

  Wellington, Cheryl L ^a   Brinkman, Ryan R ^b   O'Kusky, John R ^b   Hayden, Michael R ^a,b  

^a Centre for Molecular Medicine and Therapeutics   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CONFERENCE PAPER; GENETIC SUSCEPTIBILITY; HUMAN; HUNTINGTON CHOREA; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; TANDEM REPEAT; TRANSGENIC ANIMAL;

EID: 0030787762     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1997.tb00897.x     Document Type: Conference Paper

References (193)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375
2. Andrade MA, Bork P (1995) HEAT repeats in the Huntington's disease protein. Nature Genet 11: 115-116
3. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR (1993) The relationship between trinucleotide repeat (CAG) length and clinical features of Huntington disease. Nature Genet 4: 398-403
4. Banfi S, Servadio A, Chung M-y, Kwiatkowski Jr. TJ, McCall AE, Duvick LA, Shen Y, Roth EJ, Orr HT, Zoghbi HY (1994) Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nature Genet 7: 513-519
5. Barron L, Warner J, Porteous M, Holloway S, Simpson S, Davidson R, Brock DJH (1993) A study of the Huntington's disease associated trinucleotide repeat in the Scottish population. J Med Genet 30(12): 1003-1007
6. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119-130
7. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38: 357-366
8. Beal MF, Brouillet E, Jenkins BG, Ferrante FJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitroproprionic acid. J Neuro 13(10): 4181-4192
9. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11: 1649-1659
10. Beal MF, Hyman BT, Koroshetz W (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? TINS 17(3): 107-108
11. Beal MF, Lowall NW, Swartz KJ, Ferrante RJ, Martin JB (1989) Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3: 38-47
12. Behrens MI, Koh J, Canzoniero LMT, Sensi SL, Csernansky CA, Choi DW (1995) 3-Nitropropnonic acid induces apoptosis in cultured striatal and cortical neurons NeuroReport 6(3): 545-548
13. Benitez J, Fernandez E, Garcia Ruiz P, Robledo M, Ramos C, Yebenes J (1994) Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease. Hum Genet 94: 563-564
14. Boldin MR Goncharov TM, Golstev YV, Wallach D (1996) involvement of MACH, a novel MORT/FADD-interacting protease, in Fas/Apo-1- and TNF receptor-induced cell death. Cell 85: 803-815
15. Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Research 697: 254-257
16. Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sandberg PR (1995) Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats. Brain Research Bulletin 36(6): 549-556
17. Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MF (1993) Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 60: 1964-1967
18. Brancolini C, Benedetti M, Schneider C (1995) Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO Journal 14: 5179-5190
19. Brinkman RR, Mezei MM, Thielmann J, Almqvist E, Hayden MR (1997) The likelihood of being affected with Huntington disease by a particular age for a specific CAG size. Am J Hum Genet 60: 1202-1210
20. Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92: 7105-7109
21. Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60: 356-359
22. Burke JR, Enghild JJ, Margin ME, Joy Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Genet 2(3): 347-350
23. Burright EN, Clark HB, Servadio A, Matilla T Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT (1995) SCA1 Transgenic Mice: A Model for Neurodegeneration Caused by an Expanded CAG Trinucleotide Repeat. Cell 82: 937-948
24. Cammarata S, Caponnetto C, Tabaton M (1993) Ubiquitin-reactive neuntes in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? Neuro Lett 156: 96-98
25. Casciola-Rosen LA, Grant JA, Rosen A (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 182: 1625-1634
26. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Ness KV, Greenstreet TA, March CJ, Kronheim SR, Druck T. Cannizzaro LA, Huebner K, Black RA (1992) Molecular cloning of the interlenkin-1β converting enzyme. Science 256: 97-100
27. Chen Z, Niles EG, Pickart CM (1991) Isolation of a cDNA encoding a mammalian multiubiquitinating enzyme (E225K) and overexpression of the functional enzyme in Eschenchia coll. J Biol Chem 266: 15698-15704
28. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM (1997) Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275: 1122-1126
29. Claes S, Van Zand K, Legius E, Dom R, Malfroid M, Baro F, Godderis J, Cassiman J-J (1995) Correlations between triplet repeat expansion and clinical features in Huntington's disease. Archives of Neurology 52: 749-753
30. Coles CJ, Edmonson DE, Singer TP (1979) Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 254(12): 5141-5167
31. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 2: 324-329
32. Cortopassi GA, Shibata D, Soong N-W, Arnheim N (1992) A pattern of accumulation of a somatic deletion of mitochondnal DNA in aging human tissues. Proc Natl Acad Sci USA 89: 7370-7374
33. 32b. Cosulich SC, Green S, Clarke PR (1996) Bcl-2 regulates activation of apoptotic proteases in a cell-free system. Curr Biol 6(8): 997-1005
34. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative diseases. Ann Neurol 38: 357-366
35. Crauford D, Dodge A (1993) Mutation size and age at onset in Huntington's disease. J Med Genet 30: 1008-1011
36. Cryns VL, Bergeron L, Zhu H, Li H, Yuan J (1996) Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-beta-converting enzyme/CED-3 protease distinct from the poly(ADP-ribose)polymerase protease. J Biol Chem 271(49): 31277-31282
37. Dawburn D, De Quidt ME, Emson PC (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res 340: 251-260
38. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase - deficient mice. J Neuro 16(8): 2479-2487
39. de Grey ADNJ (1997) A proposed refinement of the mitochondrial free radical theory of aging. BioEssays 19: 161-167
40. De Rooij KE, De Koning Gans PA, Skraastad MI, Belfroid RD, Vegter-van der Vlis M, Roos RA, Bakker E, van Ommen GJ, Den Dunnen JT, Losekoot M (1993) Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instabilities extending to within the normal size range. J Med Genet 30(12): 996-1002
41. Deshaies RJ (1995) Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol 5: 428-434
42. Dragunow M, Faull RLM, Lawlor P, Beihartz EJ, Singleton K, Walker EB, Mee E (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Clin Neurosci Neuropath 6: 1053-1057
43. 41b. Duan H, Chinnaiyan AM, Hudson PC, Wing JP, He WW, Dixit VM (1996) ICE-LAP3, a novel mammalian homologue of the caenorhaloditis elegans cell death protein CED-3 is activated during Fas- and Tumor necrosis factor-induced apoptosis. J Biol Chem 271: 1621-1625
44. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He W-W, Dixit VM (1996) ICE-LAP6, a novel member of the ICE-CED-3 gene family, is activated by the cytotoxic T cell protease granzyme B-. J Biol Chem 271(28): 16720-16724
45. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Conneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falek A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Bickham Conde J, Cha J-H, Dure L, Gomez F, Ramos M, Sanchez-Ramos J, Snodgrass S, de Young M, Wexler N, Moscowitz C, Penchaszadeh G, MacFarlane H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella J, MacDonald M (1993) Trinucleotide repeat length instability in Huntington disease. Nature Genet 4: 387-392
46. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel J-P, Gusella JF, Joyner AL, MacDonald ME (1995) Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh. Science 269: 407-410
47. Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cell 44: 817-829
48. Erecinska M, Dagani F (1990) Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes. J Gen Physiol 95(4): 591-616
49. Erecinska M, Neison D (1994) Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases. J Neurochem 63(3): 1033-1041
50. Farrow SN, Brown R (1996) New members of the Bcl-2 family and their protein partners. Curr Opin Genet Devel 6: 45-49
51. Faucheu C, Blanchet AM, Collard-Dutilleul V, Lalanne JL, Diu-Hercend A (1996) Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme Eur J Biochem 236(1): 207-213
52. Faucheu C, Diu A, Chang AWE, Blanchet A-M, Miossec C, Hervé F, Collard-Dutilieul V, Gu Y, Aldape RA, Lippke JA, Rocher C, Su MS-S, Livingston DJ, Hercend T, Lalanne J-L (1995) A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO Journal 14(9): 1914-1922
53. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullnch F, Fritz LC, Trapani JA, Tomaseili KJ, Litwack G, Alnemri ES (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93: 7464-7469
54. Femandes-Alnemri T, Litwack G, Alnemn ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein CED-3 and mammalian mterleukin-1beta converting enzyme. J Biol Chem 270: 30761-30764
55. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES (1995) Mch3, A novel human apoptotic cysteine protease highly related to CPP32. Cancer Research 55(24): 6045-6052
56. Ferrante RJ, Kowall NW, Beal MF, Richardson EP, Jr., Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230: 561-563
57. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy Jr. JD, Hawkes R, Frankel WN, Copeland NG, Jenkins NA (1996) Absence epilepsy in Tottering mutant mice is associated with calcium channel defects. Cell 87: 607-617
58. Fox JB, Dandliker WB (1956) A study of some of the physical properties of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 218: 53-57
59. Freese A, DiFiglia M, Koroshetz M, Beal MF, Martin JB (1990) Characterization and mechanism of glutamate neurotoxtcity in primary striatal cultures. Brain Research 521: 254-264
60. Goldberg YP, Andrew SE, Clarke LA, Hayden MR (1993) A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet 2(6): 635-636
61. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, Koide HB, O'Kusky J, Sharp AH, Ross CA, Jirik F, Hayden MR (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum Mol Genet 5(2): 177-185
62. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Gramm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 13: 442-449
63. Gould DH, Gustine DL (1982) Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropionic acid. Neuropathol Appl Neurobiol 8: 377-393
64. Gould DH, Wilson MP, Hamar DW (1985) Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. Toxicol Lett 27: 83-89
65. Graveland GA, Williams RS, DiFiglia M (1985) A golgi study of the human neostriatum: neurons and afferent fibers. J Comp Neurol 234: 317-333
66. Greidinger EL, Miller DK, Yamin TT, Casciola-Rosen L, Rosen A (1996) Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Letters 390(3): 299-303
67. Gross NJ, Getz GS, Rabinowitz M (1969) Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat. J Biol Chem 244: 1552-1562
68. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schaptra HV (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39: 172-177
69. Hacker G, Vaux DL (1995) A sticky business. Curr Biol 5(6): 622-624
70. Harman D (1972) The biologic clock: the mitochondria? J Am Geriatr Soc 20: 145-147
71. Harper PS (1991) Huntington's Disease, WB. Saunders: London.
72. Harris JJ, Perham RN (1963) Studies on glyceraldehyde-3-phosphate dehydrogenases. Biochem J 89: 60-64
73. Hayden MR (1981) Huntington's chorea, Springer-Verlag: London, Berlin, Heidelberg.
74. Hayden MR (1991) Huntington Disease. In: Textbook of Internal Medicine, Kelley WN (ed.), 2nd Edition, pp 2179-2181, J.B. Lippincott Co.: Philadelphia.
75. Hedreen JC, Foistein SE (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54: 105-120
76. Hiort O, Sinnecker GH, Holterhus PM, Nitsche EM, Kruse K (1996) The clinical and molecular spectrum of androgen insensitivity syndromes. Am J Med Genet 63: 218-222
77. Holtzman DA, Yang S, Drubin DG (1993) Synthetic-lethal interactions identify two novel genes, SLA1 and SLA2, that control membrane cytoskeleton assembly in Saccharomyces cerevisiae. J Cell Biol 122(3): 635-644
78. Hope BT, Michael GJ, Knigge KM, Vincent SR (1991) Neuronal NADPH-diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88: 2811-2814
79. Huitorel P, Pantoloni D (1985) Bundling of microtubules by glyceraldehyde-e-phosphate dehydrogenase and its modulation by ATP. Eur J Biochem 150: 265-269
80. Huntington Study Group (1995) Huntington Study Group (HSG) policy on non-disclosure of CAG trinucleotide repeat length (CAGn) genetic (DNA) information as formulated by the HSG Committee of Michael Conneally, Kimberly Quaid, Nancy Wexler and the HSG Executive Committee (Anne Young, John Penney, Dennis Choi, Karl Kieburtz, David Oakes, Ira Shoulson - Chair) and as reviewed and approved by the HSG members (December 3, 1994 and February 13, 1995), (UnPub)
81. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983
82. Huntington G (1872) On chorea. Med Surg Rep 26: 317-321
83. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 13(2): 196-202
84. Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43(12): 2689-2695
85. Jodice C, Malaspina P, Persichetti F, Novelletto A, Spadaro M, Giunti P, Morocutti C, Terrenato L, Harding AE, Frontali M (1994) Effect of tnnucleotide repeat length and parental sex on phenotypic variation in spinocerebeilar ataxia 1. Am J Hum Genet 54: 959-965
86. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugated enzyme. J Biol Chem 271 (32): 19385-19394
87. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet 16: 44-53
88. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, Mankovich JA, Terranova M, Ghayur T (1995) Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 270(25): 15250-15256
89. 88b. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: aprimary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136
90. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet 6: 9-13
91. Komure O, Sano A, Nishino N, Yamauchi N, Ueno S, Konodoh K, Sano N, Takahashi M, Murayama N, Kondo I, Nagafuchi S, Yamada M, Kanazawa I (1995) DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: Correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 45: 143-149
92. Koroshetz WJ, Jankins BG, Rosen BR, Beal MF (1996) Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 41: 160-165
93. Korsmeyer SJ (1995) Regulators of cell death. Trends Genet 11: 101-105
94. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and ceil death. Semin Cancer Biol 4: 327-332
95. Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY (1996) Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5(9): 1311-1318
96. Koutouzis TK, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR (1994) Intrastriatal 3-nitropropionic acid: a behavioral assessment. NeuroReport 5(17): 2241-2245
97. Kowall NW, Ferrante RJ, Martin JB (1987) Patterns of cell loss in Huntington's disease. TINS 10: 24-29
98. Kramer PL, Yue Q, Gancher ST, Nutt JG, Baloh R, Smith E, Browne D, Bussey K, Lovrien E, Nelson S, Litt M (1995) A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p (letter to the editor). Am J Hum Genet 57: 182-185
99. Kuida K, Zheng TS, Na S, Kuan C-y, Yang D, Karasuyama H, Rakic P, Flavell RA (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384(6607): 368-372
100. La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, Yee W-C, Fischbeck KH (1992) Melotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet 2: 301-304
101. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fishbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79
102. Lange H, Thomer G, Hopf A, Schroder KF (1976) Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28: 401-425
103. Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS (1988) Conditions associated with Huntington's disease at death. A case-control study. Arch Neurol 45: 878-880
104. Legius E, Cuppens H, Dierick H, Van Zandt K, Dom R, Fryns J-P, Evers-Kiebooms G, Decruyenaere M, Demyttenaere K, Marynen P, Cassiman J-J (1994) Limited expansion of the (CAG)n repeat of the Huntington gene: A premutation (?). Eur J Hum Genet 2: 44-50
105. Li X-J, Li S-H, Sharp AH, Nucifora Jr. FC, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378: 398-402
106. Li X-J, Sharp AH, Li S-H, Dawson TM, Snyder SH, Ross CA(1996) Huntingtin-associated protein (HAP1): Discrete neuronal localization resemble those of neuronal nitric oxide synthase. Proc Natl Acad Sci USA 93: 4839-4844
107. 105b. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1): 147-157
108. Llinas R, Sugimori M, Hillman DE, Cherksey B (1992) Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system. TINS 15: 351-355
109. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-nitropropionic acid- exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18: 492-498
110. Ludoiph AC, Seelig MO, Ludolph A, Novitt P, Allen CN, Spencer PS, Sabri MI (1992) 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degradation in cortical explants. Neurodegen 1: 21-28
111. Maciel P, Gaspar C, DeStefano AL, Silveira I, Coutinho P. Radvany J, Dawson DM, Sudarsky L, Guimaraes J, Loureiro JEL, Nezarati MM, Corwin LI. Lopes-Cendes I, Rooke K, Rosenberg R, MacLeod P, Farrer LA, Sequeiros J, Rouleau GA (1995) Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 57: 54-61
112. MacMillan JC, Snell RG, Tyler A, Houlihan GD, Fenton I, Cheadle JP, Lazarou LP, Shaw DJ, Harper PS (1993) Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 342: 954-958
113. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice. Cell 87: 493-506
114. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR (1996) Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271(46): 28753-28756
115. Martin SJ, Green DR (1995) Protease Activation during Apoptosis: Death by a Thousand Cuts? Cell 82: 349-352
116. 113b. Martin SJ, Newmeyem DD, Mathias S, Farschon DM, Wang HG, Reed JC, Kolesnick RN, Green DR (1995) Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO Journal 14(21): 5191-5200
117. Maruyama H, Nakamura S, Matsuyama Z, Sakai T, Doyu M, Sobue G, Seto M, Tsujihata M, Oh-i T, Nishio T, Sunohara N, Takahaski R, Hayashi M, Nishino I, Ohtake T, Oda T, Nishimura M, Saida T, Matsumoto H, Baba M, Kawaguchi Y, Kakizuka A, Kawakami H (1995) Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 4(5): 807-812
118. Matsuishi T, Sakai T, Naito E, et al (1996) Elevated cerebrospinal fluid lactate/pyruvate ratio in Machado-Joseph disease. Acta Neurol Scand 93: 72-75
119. Mecicci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34: 609-616
120. Mejean C, Pons F, Benyamin Y, Roustan C (1989) Antigenic probes locate binding sites for the glycolutic enzymes glyceraldehyde-3-phosphate dehydrogenase, aldolase and phosphofructokinase on the actin monomer in microfilaments. Biochem J 264: 671-677
121. Menzies RA, Gold PH (1971) The turnover of mitochondria in a variety of tissues of young adult and aged rats. J Biol Chem 246: 2425-2429
122. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer J, DeRiel JK, Sirover MA (1991) A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 88: 8460-8464
123. Minn AJ, Velez P, Schendel SL, bang H, Muchmore SW, Fesik SW, Fill M, Thompson CB (1997) Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 385: 353-357
124. Mori Y, Friedrich T, Kim M-S, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furiuchi T, Mikoshiba K, Imoto K, Tanabe T, Numa S (1991) Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350: 398-402
125. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux SM, Yamin T-T, Yu VL, Nicholson DW (1995) Molecular cloning and pro-apoptotic activity of ICErelll and ICErellll, members of the ICE/CED-3 family of cysteine proteases J Biol Chem 270(26): 15870-15876
126. Munn AL, Stevenson BJ, Geli MI, Reizman H (1996) end5, end6, and end7: Mutations that cause actin delocalization and block the internalization step of endocytosis in Saccharomyces cerevisiae. Mol Biol Cell 6: 1721-1742
127. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko NJ, Scaffidi C, Bretz JD, Zhang M, Gentz R, et al (1996) Flice, a novel FADD-homologous ICE/CED-3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
128. Myers RH, Leavitt J, Kamer LA, Farrer L, Jagedeesh J, McFarlane H, Mastromouro CA, Mark RJ, Gusella JF (1989) Homozygote for Huntington disease. Am J Hum Genet 45: 615-618
129. Na S, Hincapie M, McCusker JH, Haber JE (1995) MOP2 (SLA2) affects the abundance of the plasma membrane H+-ATPase of Saccharomyces cerevisiae. J Biol Chem 270(12): 6815-6823
130. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, Tanaka Y, Kirushima H, Umino K, Kurosawa H, Furukawa T, Hikei K, Inoue T, Sano A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet 6: 14-18
131. Nagy E, Rigby WF (1995) Glyceraldehyde-e-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem 270: 2755-2763
132. Nance MA (1996) Huntington disease - another chapter rewritten. Editorial review. Am J Hum Genet 59(1): 1-6
133. Nasir J, Goldberg YP, Hayden MR (1996) Huntington disease: new insights into the relationship between CAG expansion and disease Invited Review. Hum Mol Genet 5: 1431-1435
134. Nasir S, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borouski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the murine Huntington disease gene results in early post-implantation embryonic lethality and behavioral and morphological abnormalities in heterozygotes. Cell 81: 811-823
135. 131b. Newmeyer DD, Farschon DM, Reed JC (1994) Cell-free apoptosis in Xeniopus egg extracts inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79: 353-364
136. Nicholson DW (1996) ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotech 14: 297-301
137. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43
138. Norremolle A, Riess O, Epplen JT, Fenger K, Hasholt L, Sorenson SA (1993) Trinucleotide repeat elongation in the Huntington gene in Huntington disease patients from 71 Danish families. Hum Mol Genet 2: 1475-1476
139. Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F, Pergola M, Del Sanno L., MacDonald ME, Gusella JF, Frontali M (1994) Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease Hum Mol Genet 3(1): 93-98
140. Onodera O, Roses AD, Tsuji S, Vance JM, Strittmatter WJ, Burke JR (399) Toxicity of expanded polyglutamine-domain proteins in Escherichia coli. FEBS Letters 135: 139
141. Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neuro 16(9): 3019-3025
142. Parker, W.D., Boyson SJ, Luder AS, Parks JK (1990) Evidence for a defect in NADH: uibiquinone oxidoreductase (complex 1) in Huntington's disease. Neurology 40: 1231-1234
143. Perutz MF, Johnson T, Suzuki M, Finch JT (1994) Glutamine repeats as polar zippers their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 91: 5355-5358
144. Petit PX, Susin S-A, Zamzami N, Mignotte B, Kroemer G (1996) Mitochondria and programmed cell death: back to the future. FEBS Letters 396: 7-13
145. Protera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15(5): 3775-3787
146. Ranum LPW, Chung M-y, Banfi S, Bryer A, Schut LJ, Ramesar R, Duvick LA, McCall AE, Subramony SH, Goldfarb L, Gomez C, Sandkuijl LA, Orr HT, Zoghbi HY (1994) Molecular and clinical correlations in spinocerebellar ataxia type 1 (SCA1): evidence for familial effects on the age of onset. Am J Hum Genet 55: 244-252
147. Reed JC (1994) Bcl-2 and the regulation of programmed cell death (Review). J Cell Biol 124(1-2): 1-6
148. Richardson Jr. EP (1990) Huntington's disease: some recent neuropathological studies. Neuropathol Appl Neurobiol 16: 451-460
149. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voom P (1995) Preferential loss of preproenkephalin versus preprotakykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38: 852-861
150. Ronai Z (1993) Glycolytic enzymes as DNA binding proteins. Int J Biochem 25: 1073-1076
151. Ross CA (1995) When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15: 493-496
152. Rubinsztein DC, Barton DE, Davison BCC, Ferguson-Smith MA (1993) Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number. Hum Mol Genet 2: 1713-1715
153. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman J-J, Chotai K, Connarty M, Craufurd D, Curtis A, Curtis D, Davidson MJ, Differ A-M, Dode C, Dodge A, Frontali M, Ranen MG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Jackson A, Kaplan J-C, Losekoot M, MacMillan JC, Morrison P, Trottier Y, Novelletto A, Simpson SA, Theilmann J, Whittaker JL, Folstein SE, Ross CA, Hayden MR (1996) Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington's disease gene (HD) reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 59: 16-22
154. Schiffer D, Attanasino A, Chio A, Migheli A, Pezzulo T (1994) Ubiquitinated dystrophic neuntes suggest corticospinal derangement in patients with amyotrophic lateral sclerosis. Neuro Lett 180: 21-24
155. Schulz JB, Matthews RT, Jenkins BG, Ferrante, R.J., Siewk D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR, Beal MF (1995) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neuro 15(12): 8419-8429
156. Schulze H, Schuler A, Stüber, Dobeli H, Langen H, Huber G (1993) Rat Brain Glyceraldehyde-3-Phosphate Dehydrogenase Interacts with the Recombinant Cytopiasmic Domain of Alzheimer's beta-Amyloid Precursor Protein. J Neurochem 60(5): 1915-1992
157. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY (1995) Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet 10(1): 94-98
158. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama YI, Matsuda H, Tsujimoto Y (1996) Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13: 21-29
159. Sigiyama H, Hainfeller JA, Yoshimura M, Budka H (1994) Neocortical changes in Parkinson's disease, revisited. Clin Neuropath 13: 55-59
160. Simpson SA, Davidson MJ, Barron LH (1993) Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease. J Med Genet 30(12): 1014-1017
161. Singh R, Green MR (1993) Sequence specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenases. Science 259: 365-368
162. Skulachev VP (1996) Why are mitochondria involved in apoptosis? FEBS Letters 387: 7-10
163. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P. MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet 4(4): 393-397
164. Somers M, Engelborghs Y, Baert J (1990) Analysis of the binding of glyceraldehyde-3-phosphate dehydrogenase to microtubules, the mechanism of bundle formation and the linkage effect. Eur J Biochem 193: 437-444
165. Song Q, Wei T, Lees-Miller S, Alnemri E, Watters D, Lavin MF (1997) Resistance of actin to cleavage during apoptosis. Proc Natl Acad Sci USA 94(1): 157-162
166. Soong B-W, Wang JT (1995) A comparison of the Huntington's disease associated trinucleotide repeat between Chinese and white populations. J Med Genet 32: 404-408
167. Soong N-W, Hinton DR, Cortpassi G, Arnheim N (1992) Mosaicism for a specific mitochondrial DNA mutation in adult human brain. Nature Genet 2: 318-323
168. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES (1996) The Ced3/Interteukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mcn2 alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 271(43): 27099-27106
169. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 2(10): 1547-1549
170. Taddei N, Ligun G, Sorbi S, Amaducci L, Camici G, Cecchi C, Ramponi G (1993) Cerebral soluble ubiquitin is increased in patients with Alzheimer's disease. Neuro Lett 151: 158-161
171. Takai D, Inoue K, Shisa H, Kagawa Y, Hayashi JI (1995) Age-associated changes of mitochondrial translation and respiratory function in mouse brain. Biochem & Biophys Res Comm 217: 668-674
172. Takiyama Y, Igarashi S, Rogaeva EA, Endo K, Rogaev El, Tanaka H, Sherrington R, Sanpei K, Liang Y, Saito M, Tsuda T, Takano H, Ikeda M, Lin C, Chi H, Kennedy JL, Lang AE, Wherrett JR, Segawa M, Nomura Y, Yuasa T, Weissenbach J, Yoshida M, Nishizawa M, Kidd KK, Tsuji S, St George-Hyslop PH (1995) Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Hum Mol Genet 4(7): 1137-1146
173. Tellez-Nagel I, Johnson AB, Terry RD (1973) Ultrastructural and histochemical study of cerebral biopsies in Huntington's chorea. Adv Neurol 1: 387-397
174. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirer GG, Salvesen GS, Dixit VM (1995) Yama/CPP32beta, a Mammalian Homolog of CED-3, Is a CrmA-Inhibitable Protease That Cleaves the Death Substrate Poly(ADP-Ribose) Polymerase. Cell 81: 801-809
175. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA (1995) DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathotogical Conditions. Exp Neurol 133: 265-272
176. Trottier Y, Biancalana V, Mandel JL (1994) Instability of CAG repeats in Huntington's disease: relationship to parental transmission and age of onset. J Med Genet 31(5): 377-382
177. Vahedi K, Joutel A, Van Bogaert P, Ducros A, Maciazeck J, Bach JR Bousser MG, Tournier-Lasserve E (1995) A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 37(3): 289-293
178. Vincenz C, Dixit VM (1997) Fas-associated death domain protein interieukin-1 beta-converting enzyme 2 (FLICE2), an ICE/CED-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem 272(10): 6578-6583
179. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson Jr. EP (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44: 559-577
180. Wallace DC (1992) Mitochondrial Genetics: A paradigm for aging and degenerative diseases? Science 256: 628-632
181. Wang L, Miura M, Bergeron L, Zhu H, Yuan J (1994) Ich1, an lce/ced-3- related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739-750
182. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL (1996) Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. Embo J 15: 1012-1020
183. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H (1997) H1P1: A huntingtin interacting protein isolated by the yeast twohybrid system. Hum Mol Genet 6: 487-495
184. Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, Snodgrass SR, Shoulson I, Gomez F, Ramos Arroyo MA (1987) Homozygotes for Huntington's disease. Nature 326: 194-197
185. Wong-Riley MTT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. TINS 12(3): 94-101
186. Wu D, Wallen HD, Nuñez G (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275: 1126-1129
187. Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and eel! death. Blood 88(2): 386-401
188. 183b. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-l, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
189. Yuan J-Y, Shaham S, Ledoux S, Ellis HJM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641-652
190. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182: 367-377
191. Zeitlin S, Liu J-P, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet 11: 155-162
192. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amox D, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha1A-voltage-dependent calcium channel. Nature Genet 15: 62-69
193. Zühlke C, Riess O, Shroder K, Siedlaczck I, Epplen JT, Engel W, Thies U (1993) Expansion of the (CAG)n repeat causing Huntington's disease in 352 patients of German origin. Hum Mol Genet 2: 1467-1469